Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications.
作者： Cynthia Osborne , Paschal Wilson , Debu Tripathy
DOI: 10.1634/THEONCOLOGIST.9-4-361
关键词:
摘要: Abstract Learning Objectives After completing this course, the reader will be able to: Differentiate between the actions of oncogenes and tumor suppressor genes in the …
alphamedpress.org
oup.com参考文章(129)
Brammar Wj, Walker Ra, Varley Jm, Whittaker Jl, Swallow Je, Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Oncogene. ,vol. 1, pp. 423- 430 ,(1987)
Daniel Pinkel, Richard Segraves, Damir Sudar, Steven Clark, Ian Poole, David Kowbel, Colin Collins, Wen-Lin Kuo, Chira Chen, Ye Zhai, Shanaz H. Dairkee, Britt-marie Ljung, Joe W. Gray, Donna G. Albertson, High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays Nature Genetics. ,vol. 20, pp. 207- 211 ,(1998) , 10.1038/2524
Donna G. Albertson, Bauke Ylstra, Richard Segraves, Colin Collins, Shanaz H. Dairkee, David Kowbel, Wen-Lin Kuo, Joe W. Gray, Daniel Pinkel, Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nature Genetics. ,vol. 25, pp. 144- 146 ,(2000) , 10.1038/75985
Loda M, Baldi F, Baldi A, Pagano M, Giordano A, Caputi M, Esposito, De Luca A, Groger Am, Giordano Gg, Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Research. ,vol. 57, pp. 3381- 3385 ,(1997)
T. Kurosaki, B. Noble, H. Anton-Culver, D. Gordon, L. S. Friedman, B. A. J. Ponder, G. Casey, S. A. Gayther, Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population American Journal of Human Genetics. ,vol. 60, pp. 313- 319 ,(1997)
Massimo Loda, Cristina Magi-Galluzzi, Michele Pagano, Barry Cukor, Molly Wanner, Blake Cady, Philip Lavin, Puay Tan, Giulio Draetta, Peter Worland, The Cell Cycle Inhibitor p27 Is an Independent Prognostic Marker in Small (T1a,b) Invasive Breast Carcinomas Cancer Research. ,vol. 57, pp. 1259- 1263 ,(1997)
Bienstock Rj, Barrett Jc, Darden T, Wiseman R, Pedersen L, Molecular Modeling of the Amino-Terminal Zinc Ring Domain of BRCA1 Cancer Research. ,vol. 56, pp. 2539- 2545 ,(1996)
J Peto, D F Easton, D Ford, Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. American Journal of Human Genetics. ,vol. 57, pp. 1457- 1462 ,(1995)
Sheryl Redlin-Frazier, Patrice S. Obermiller, Jeffrey T. Holt, Allison R. Hatmaker, David L. Tait, Ovarian cancer BRCA1 gene therapy: Phase I and II trial differences in immune response and vector stability. Clinical Cancer Research. ,vol. 5, pp. 1708- 1714 ,(1999)
R M Hudziak, G D Lewis, M Winget, B M Fendly, H M Shepard, A Ullrich, p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Molecular and Cellular Biology. ,vol. 9, pp. 1165- 1172 ,(1989) , 10.1128/MCB.9.3.1165